Kharitonova A M, Grigor'eva L V, Antsiferova N G, Radkevich S A, Vetkova L G
Zh Mikrobiol Epidemiol Immunobiol. 1986 Feb(2):14-9.
The acute and chronic toxicity, influence on hematological characteristics and sensitizing properties of P. aeruginosa polyvalent corpuscular vaccine have been studied in experiments on 3 species of animals. The acute experiment has shown that the LD50 of the preparation contains not less than 7800 million cells, which is almost 160 times higher than the recommended immunizing dose (500 million cells). The safety of the preparation is confirmed by the data obtained in the histological and histochemical investigations of the tissues and organs of animals subjected to multiple immunizations with the vaccine. These investigations have revealed no pathological changes in the animals. During the study of the chronic toxicity of the preparation the hematological characteristics of the animals have been found to remain within normal limits. The vaccine has been shown to possess low sensitizing activity, which is manifested by the absence of severe reactions to allergic skin tests with different bacterial allergens (specific allergens obtained from P. aeruginosa and allergens obtained from other bacterial species), made on completion of the course of immunization with the vaccine.
在对3种动物进行的实验中,研究了铜绿假单胞菌多价微粒疫苗的急性和慢性毒性、对血液学特征的影响以及致敏特性。急性实验表明,该制剂的半数致死量(LD50)不少于78亿个细胞,几乎比推荐免疫剂量(5亿个细胞)高160倍。对多次接种该疫苗的动物的组织和器官进行组织学和组织化学研究所得的数据证实了该制剂的安全性。这些研究未发现动物有病理变化。在研究该制剂的慢性毒性时,发现动物的血液学特征保持在正常范围内。已证明该疫苗具有低致敏活性,这表现为在完成疫苗免疫疗程后,用不同细菌过敏原(从铜绿假单胞菌获得的特异性过敏原和从其他细菌物种获得的过敏原)进行过敏性皮肤试验时未出现严重反应。